AMLX FY 2021 Earnings — Amylyx Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMLXAmylyx Pharmaceuticals, Inc.

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$83M

Net Income

-$88M

EPS (Diluted)

$-1.52

Cash Flow

Operating Cash Flow

-$75M

Free Cash Flow

-$75M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$106M

Total Liabilities

$257M

Stockholders' Equity

-$151M

Cash & Equivalents

$50M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$650,000	-100.0%
Gross Profit	$0	-$24M	+100.0%
Operating Income	-$83M	-$39M	-112.0%
Net Income	-$88M	-$42M	-108.0%